Mathew Stephens
Verkoop & Marketing bij Endomagnetics Ltd.
Profiel
Mathew Stephens is currently working as the Commercial Director at Endomagnetics Ltd.
He started this position in 2016.
Prior to his current role, he worked as the Principal at S.R.A.
Developments Ltd.
Mathew completed his undergraduate degree at the University of Bath.
Actieve functies van Mathew Stephens
Bedrijven | Functie | Begin |
---|---|---|
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Verkoop & Marketing | 01-08-2013 |
Eerdere bekende functies van Mathew Stephens
Bedrijven | Functie | Einde |
---|---|---|
S.R.A. Developments Ltd.
S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Corporate Officer/Principal | - |
Opleiding van Mathew Stephens
University of Bath | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
S.R.A. Developments Ltd.
S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |